SCHEMBL8064022

SCHEMBL8064022

Cc1ccc(C=CC(=O)Nc2ccc(Cl)cc2C(=O)O)cc1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 2/20 0.74
TRPA1 O75762 2/20 0.64
POLB P06746 2/20 0.64
TRPM2 O94759 4/20 0.61
EGFR P00533 1/20 0.59
KCNK2 O95069 1/20 0.56
KDM4E B2RXH2 4/20 0.56
SMN1; SMN2 Q16637 3/20 0.56
RAB9A P51151 3/20 0.56
MEN1 O00255 2/20 0.56
NPC1 O15118 2/20 0.56
KMT2A Q03164 2/20 0.56
LMNA P02545 2/20 0.56
PPARG P37231 1/20 0.56
PPARA Q07869 1/20 0.56
MAPT P10636 2/20 0.56
HSD17B10 Q99714 1/20 0.56
MAOA P21397 1/20 0.55
MAOB P27338 1/20 0.55
ALDH1A1 P00352 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8064019 1.00 TP53 (0.74) TP53TRPA1POLBTRPM2EGFR
SCHEMBL8065883 0.92 TRPA1 (0.75) TP53TRPA1POLBTRPM2EGFR
SCHEMBL8065880 0.92 TRPA1 (0.75) TP53TRPA1POLBTRPM2EGFR
SCHEMBL8065950 0.90 TP53 (0.70) TP53TRPA1POLBTRPM2EGFR
SCHEMBL8065953 0.90 TP53 (0.70) TP53TRPA1POLBTRPM2EGFR
SCHEMBL8060454 0.88 EGFR (0.75) TP53TRPA1TRPM2EGFRKDM4E
SCHEMBL8060457 0.88 EGFR (0.75) TP53TRPA1TRPM2EGFRKDM4E
SCHEMBL8059603 0.87 TRPA1 (0.68) TP53TRPA1POLBTRPM2EGFR
SCHEMBL8059600 0.87 TRPA1 (0.68) TP53TRPA1POLBTRPM2EGFR
SCHEMBL8065971 0.87 TRPA1 (0.68) TP53TRPA1POLBTRPM2EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6127392-A A MUSCLE RELAXANT FOR TREATMENT OF DISORDERS ASSOCIATED WITH SMOOTH MUSCLE CONTRACTION VIA POTASSIUM CHANNEL AND CHLORIDE CHANNEL MODULATION; INOTROPIC AGENT AMERICAN HOME PRODUCTS CORPORATION (US) 2000-10-03 US disclosed
US-6046239-A USED IN THE TREATMENT OF DISORDERS ASSOCIATED WITH SMOOTH MUSCLE CONTRACTION, VIA POTASSIUM CHANNEL AND CHLORIDE CHANNEL MODULATION SUCH AS URINARY INCONTINENCE, ASTHMA, ANGINA, PREMATURE LABOR, CONGESTIVE HEART FAILURE AMERICAN HOME PRODUCTS CORPORATION (US) 2000-04-04 US disclosed